Oncolys BioPharma Inc. logo

Oncolys BioPharma Inc.

TSE:4588.T

Overview | Financials
Company Name Oncolys BioPharma Inc.
Symbol 4588.T
Currency JPY
Price 623
Market Cap 15,488,005,526
Dividend Yield 0%
52-week-range 420 - 918
Industry Biotechnology
Sector Healthcare
CEO Mr. Yasuo Urata M.Sc.
Website https://www.oncolys.com

An error occurred while fetching data.

About Oncolys BioPharma Inc.

Oncolys BioPharma Inc. engages in the research, development, manufacture, sale, import, and export of oncolytic viruses, drugs and medicines, and tumor diagnostic agents in Japan, the rest of Asia, and the United States. Its product pipeline includes Telomelysin (OBP-301), an oncolytic adenovirus that is in phase II clinical trial for

Related Stocks

Ohki Healthcare Holdings Co.,Ltd. logo

Ohki Healthcare Holdings Co.,Ltd.

3417.T

850 JPY

Precision System Science Co., Ltd. logo

Precision System Science Co., Ltd.

7707.T

239 JPY

Wakamoto Pharmaceutical Co.,Ltd. logo

Wakamoto Pharmaceutical Co.,Ltd.

4512.T

243 JPY

DVx Inc. logo

DVx Inc.

3079.T

943 JPY

Create Medic Co., Ltd. logo

Create Medic Co., Ltd.

5187.T

925 JPY

OLBA HEALTHCARE HOLDINGS, Inc. logo

OLBA HEALTHCARE HOLDINGS, Inc.

2689.T

2,094 JPY

Satudora Holdings Co.,Ltd. logo

Satudora Holdings Co.,Ltd.

3544.T

829 JPY

Advantage Risk Management Co., Ltd. logo

Advantage Risk Management Co., Ltd.

8769.T

546 JPY

Carna Biosciences, Inc. logo

Carna Biosciences, Inc.

4572.T

306 JPY

Japan Hospice Holdings Inc. logo

Japan Hospice Holdings Inc.

7061.T

1,655 JPY

Financials

Numbers are in millions USD

Numbers are in millions USD